Results 31 to 40 of about 26,219 (238)

Dermatomyositis with Kaposi’s Sarcoma in a Patient without Human Immunodeficiency Virus-1 Infection

open access: yesCanadian Journal of Gastroenterology, 1991
The first case of dermatomyositis complicating cutaneous and visceral Kaposi’s sarcoma is presented in a 75-year-old man without human immunodeficiency virus infection.
Dana Liang   +4 more
doaj   +1 more source

Pulmonary Kaposi's sarcoma—an atypical clinical presentation

open access: yesInternational Journal of Infectious Diseases, 2022
HIV-associated Kaposi's sarcoma is an angioproliferative neoplasia caused by infection with human herpesvirus 8. It typically presents with mucocutaneous involvement. Pulmonary Kaposi's sarcoma is rare, and an uncommon form of initial presentation of the
Ana Luísa Ramos   +4 more
doaj   +1 more source

Iron: a target for the management of Kaposi's sarcoma? [PDF]

open access: yes, 2004
SCOPUS: ar.jinfo:eu-repo/semantics ...
Thierry Simonart   +57 more
core   +2 more sources

Does the knowledge of the human immunodeficiency virus serostatus influence the clinical diagnostic proficiency of Kaposi's sarcoma?

open access: yesSouth African Family Practice, 2013
Objectives: Kaposi's sarcoma is an acquired immunodeficiency syndrome (AIDS)-defining illness. A spectrum of non- Kaposi's sarcoma clinical and histopathological mimickers contributes to the potential over- or underdiagnosis of Kaposi's sarcoma.
L.J. van Bogaert
doaj   +1 more source

KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development [PDF]

open access: yes, 2007
Kaposi's sarcoma (KS) is a highly and abnormally vascularized tumor-like lesion affecting the skin, lymphnodes and viscera, which develops from early inflammatory stages of patch/plaque to late, nodular tumors composed predominant of spindle cells (SC ...
Pyakurel, P.   +4 more
core   +1 more source

Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not"

open access: yesBMC Nephrology, 2007
Background Imatinib is a tyrosine-kinase inhibitor; for which there is limited information regarding its effects on AIDS Kaposi's sarcoma and none in patients with transplant-associated Kaposi's sarcoma.
Correa-Rotter Ricardo   +2 more
doaj   +1 more source

Disseminated Kaposi Sarcoma [PDF]

open access: yesClinical Practice and Cases in Emergency Medicine, 2021
Case Presentation: A 28-year-old male with a recent diagnosis of human immunodeficiency virus presented to the emergency department with odynophagia and dysphagia for a month. Physical exam revealed Kaposi sarcoma partially occluding the airway. Point-of-care ultrasound was used to assist with the diagnosis of reactive lymphadenopathy, and computed ...
Goyack, Laura, Heimann, Matthew
openaire   +5 more sources

Fatal outcome in classic Kaposi's sarcoma [PDF]

open access: yes, 2010
First described in 1872, Kaposi's sarcoma is defined as a rare multifocal tumor that originates in the endothelial cells and presents with cutaneous and extracutaneous manifestations. The classic form is most common in elderly men and progression is slow.
Almeida, Fernando Augusto de   +4 more
core   +3 more sources

Kaposi's sarcoma with a non-Hodgkin's lymphoma. Its association in a male homosexual with human T-cell lymphotropic virus type III infection [PDF]

open access: yes, 1986
Combined tumor syndromes, specifically reticuloendothelial malignancies and Kaposi’s sarcoma, have long been recognized. With the recognition of the acquired immunodeficiency syndrome (AIDS), several patients with concurrent non-Hodgkin’s lymphoma and ...
Cortez, L. M.   +5 more
core   +1 more source

Early initiation of fast‐track care for persons living with HIV initiating dolutegravir‐based regimens during a period of severe civil unrest in Port‐au‐Prince, Haiti: a pilot randomized trial

open access: yesJournal of the International AIDS Society
Introduction Differentiated service delivery (DSD) models have been widely implemented for patients in stable HIV care. However, DSD has rarely been offered to newly diagnosed patients.
Jean Bernard Marc   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy